From: Breast cancer distant recurrence lead time interval by detection method in an institutional cohort
By order of entry into the model: | HzR (95% CI) | p value | Wald chi-square | Model Chi-square change | df |
---|---|---|---|---|---|
TNM Stage I | reference | <.001 | 200.86 | 353.10 | 2 |
TNM Stage II | 3.30 (2.47, 4.42) | Â | 64.96 | Â | Â |
TNM Stage III | 9.19 (6.70, 12.60) | Â | 190.03 | Â | Â |
HR/HER2 status: initial diagnosis | |||||
 HR+/HER2- | reference | <.001 | 48.50 | 55.00 | 2 |
 HR+ or HR−/HER2+ | .86 (.66, 1.13) |  | 1.13 |  |  |
 HR−/HER2- | 2.22 (1.73, 2.84) |  | 40.31 |  |  |
Histological grade primary tumor | |||||
 Low/Intermediate | reference | <.001 | 7.89 | 29.04 | 1 |
 High | 1.49 (1.13, 1.98) |  |  |  |  |
Detection method | |||||
 MamD | reference | <.001 | 25.84 | 8.51 | 1 |
 PtD | 1.80 (1.43, 2.25) |  |  |  |  |